SR&ED for Life Sciences & Health Tech
From pre-clinical research to diagnostic tool development, life sciences work frequently qualifies for SR&ED tax credits — including refundable credits that return cash to your business regardless of profitability.
Check If Your Work QualifiesWhat Qualifies in Life Sciences & Health Tech?
- Pre-clinical and clinical research involving technological uncertainty about biological, chemical, or device behaviour
- Medical device design and testing — particularly where performance targets are unknown and must be experimentally determined
- Diagnostic tool development: novel assays, sensors, imaging systems, or biomarker identification
- Health informatics and data systems where novel algorithms or architectures are required
- Drug formulation and delivery mechanisms involving non-standard materials or release profiles
- Regulatory-driven testing that involves genuine technological uncertainty — not merely confirmatory work
How Bill C-15 (2026) Affects Life Sciences & Health Tech
The expanded phase-out thresholds — from $10M–$50M to $15M–$75M taxable capital — mean more mid-sized life sciences companies retain full access to the enhanced 35% refundable credit as they scale. The new Pre-Claim Approval Process is especially valuable for multi-year clinical projects where advance certainty on eligibility can significantly reduce risk.
Why a Former CRA SR&ED Claims Reviewer Makes the Difference
Kazem Naderi spent years at the CRA reviewing and assessing SR&ED claims across industries. He knows exactly what CRA looks for, what documentation survives scrutiny, and what language gets claims approved. That insider perspective is something no other consultant can offer.
Book a Free Eligibility Call